Central Pharmaceutical JSC No2 (HSTC:DP2) EV-to-EBIT: (As of Jul. 19, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

HSTC:DP2 Central Pharmaceutical JSC No2 HSTC:DP2
23 GF Score
Price ₫4,900.00
View Full Analysis

What is Central Pharmaceutical JSC No2 EV-to-EBIT?

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Central Pharmaceutical JSC No2's Enterprise Value is ₫0.00 Mil. Central Pharmaceutical JSC No2 does not have enough years/quarters to calculate its EBIT for the trailing twelve months (TTM) ended in . 20. Therefore, GuruFocus does not calculate Central Pharmaceutical JSC No2's EV-to-EBIT at this moment.

The historical rank and industry rank for Central Pharmaceutical JSC No2's EV-to-EBIT or its related term are showing as below:

HSTC:DP2's EV-to-EBIT is not ranked *
in the Healthcare Providers & Services industry.
Industry Median: 15.86
* Ranked among companies with meaningful EV-to-EBIT only.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. Central Pharmaceutical JSC No2's Enterprise Value for the quarter that ended in . 20 was ₫0.00 Mil. Central Pharmaceutical JSC No2 does not have enough years/quarters to calculate its EBIT for the trailing twelve months (TTM) ended in . 20. Therefore, GuruFocus does not calculate Central Pharmaceutical JSC No2's Earnings Yield (Joel Greenblatt) % at this moment.

Central Pharmaceutical JSC No2  (HSTC:DP2) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Central Pharmaceutical JSC No2's Earnings Yield (Joel Greenblatt) % for the quarter that ended in . 20 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: . 20 ) =EBIT / Enterprise Value (Q: . 20 )
=/
= %

Central Pharmaceutical JSC No2 EV-to-EBIT Related Terms

Central Pharmaceutical JSC No2 EV-to-EBIT Historical Data

* Premium members only.

The historical data trend for Central Pharmaceutical JSC No2's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Central Pharmaceutical JSC No2 EV-to-EBIT Chart

Central Pharmaceutical JSC No2 Annual Data
Trend
EV-to-EBIT

Central Pharmaceutical JSC No2 Semi-Annual Data
EV-to-EBIT

HSTC:DP2 vs : EV-to-EBIT Comparison

For the Pharmaceutical Retailers subindustry, Central Pharmaceutical JSC No2's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Central Pharmaceutical JSC No2 EV-to-EBIT vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Central Pharmaceutical JSC No2's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Central Pharmaceutical JSC No2's EV-to-EBIT falls into.


HSTC:DP2
23GF Score
Central Pharmaceutical JSC No2 HSTC:DP2
EV-to-EBIT is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Central Pharmaceutical JSC No2 EV-to-EBIT Calculation

Central Pharmaceutical JSC No2's EV-to-EBIT for today is calculated as:

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=0.000/
=

Central Pharmaceutical JSC No2 Business Description

Comparable Companies
Address No. 9 Tran Thanh Tong, Bach Dang Ward, Hai Ba Trung District, Hanoi, VNM
Central Pharmaceutical JSC No2 is engaged in the Trading of medicinal materials, pharmaceutical materials, chemicals, essential oils, modern medicines, traditional medicine drugs, cosmetics, and nutritious foods. Some of its products include Gentamycin injection solution 80; Genatreson Skin Cream; Ferimax Hard Capsules and others.
23GF Score

Get the complete analysis for HSTC:DP2

EV-to-EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₫4,900.00
Price